| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.26 | 3e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 6e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.26 | 1e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.24 | 4e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.001 |